BOSTON and BIRMINGHAM,England, April 9, 2013 /PRNewswire/ --Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for its cloud-based BENCHlab CNV solution for genetic variant storage and analysis with West Midlands Regional Genetics Laboratory (WMRGL) at Birmingham Women's Hospital NHS Foundation Trust (BWHFT). WMRGL is the first UK-based lab to license the Cartagenia BENCHlab CNV platform, a software and database solution created in collaboration with genetics labs and clinical experts to automate and speed up testing practices and develop high-quality lab reports. For WMRGL, the Cartagenia solution will support the storage, filtration, analysis and interpretation of CNV data produced by the laboratories' pre- and post-natal testing services. The BENCHlab solutions can also handle NGS data generated as gene panels, exomes and whole genomes and can automatically generate clinical reports specific to a laboratory's needs. The Cartagenia BENCHlab platform will also help link clinical and phenotypic data from the Fetal Medicine Centre at BWHFT with genetic data generated at WMRGL for submission into the UK EACH (Evaluation of Array Comparative Genomic Hybridisation in Prenatal Diagnosis of Fetal Anomalies) … Continue reading →

NEW YORK--(BUSINESS WIRE)-- Inova Translational Medicine Institute, a not-for-profit research initiative bringing personalized medicine to the public, has chosen a joint solution by Medidata Solutions (MDSO) and Digital Infuzion to support a unique observational study involving the correlation between a childs genetic profile, their development and their long-term health. Together, Medidata and Digital Infuzion will deliver a web-based portal and cloud technology for collecting patient data, reviewing study progress and providing subjects with access to surveys and study information. In a unique combination of genomics and clinical research, Inova is studying 2,500 families to analyze and predict the relationship between genetics and childhood developmental issues. The study will follow the infants for the first 1,000 days, starting in utero, and identify any health and development issues. By comparing these with the genetic profile of each family (child, mother and father), Inova hopes to identify specific genomic information associated with the medical issues, ultimately leading to new treatment and prevention pathways. The joint solution will bring together Medidata Ravethe industry-leading system for capturing, managing and reporting clinical research datawith Digital Infuzions N of 1 Health Research Platforma technology service that provides tools for physicians and other care team members to collect, … Continue reading →

Celulas Madre stem cell testimonio By: Javier Alejandre … Continue reading →

Stem cell search A 36-year-old Perth mother is desperately searching for a stem cell donor to overcome her cancer battle. By: SunriseOn7 … Continue reading →

Stem cell treatment for Muscular Dystrophy A 12 years old male child presented with complaints of generalized pain, loss of appetite, progressive weakness in upper lower extremities along with neck ... By: StemRx BioScience … Continue reading →

The Vatican on Thursday will organise a conference to promote adult stem cell research as an alternative to research using destroyed human embryos, which is considered by the Roman Catholic Church as deeply unethical and less effective. Cardinal Gianfranco Ravasi, head of the Vatican's Pontifical Council for Culture, at a briefing on Tuesday said several leading world scientists would attend including Britain's John Gurdon, winner of the Nobel Prize for Medicine last year. Ravasi said the upcoming meeting showed that the Church did "not intervene only negatively" in the debate on stem cell research and that its commitment to finding cures was not only "words". The cardinal said he would personally present Pope Francis with the results of the three-day conference, which will include examples of successful therapy using adult stem cells. The conference follows a similar one held in November 2011 and like the previous one it is being organised together with the US laboratory NeoStem, headed up by Robin Smith, who is also president of the "Stem for Life Foundation". Read more from the original source: Vatican prepares for adult stem cell conference … Continue reading →

The Vatican will organise a conference to promote adult stem cell research as an alternative to research using destroyed human embryos, which is considered by the Roman Catholic Church as deeply unethical and less effective. Cardinal Gianfranco Ravasi, head of the Vatican's Pontifical Council for Culture, at a briefing on Tuesday said several leading world scientists would attend on Thursday including Britain's John Gurdon, winner of the Nobel Prize for Medicine last year. Ravasi said the upcoming meeting showed the Church did 'not intervene only negatively' in the debate on stem cell research and its commitment to finding cures was not only 'words'. The cardinal said he would personally present Pope Francis with the results of the three-day conference, which will include examples of successful therapy using adult stem cells. The conference follows a similar one held in November 2011 and like the previous one it is being organised together with the US laboratory NeoStem, headed up by Robin Smith, who is also president of the 'Stem for Life Foundation'. More: Vatican prepares adult stem cell talks … Continue reading →